×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Lysosomal Storage and Lipid Trafficking Therapy in CBS/PSP
therapeutic
1,433 words
KG: ent-dise-bfd8f32d
2026-03-26
section:therapeutics
kind:therapeutic
topic:psp
topic:cbs
state:published
Contents
Lysosomal Storage and Lipid Trafficking Therapy in CBS/PSP
💊
Therapeutic Info
Name
Lysosomal Storage and Lipid Trafficking Therapy in CBS/PSP
Summary
Comprehensive review of lysosomal dysfunction and lipid trafficking defects in 4R-tauopathies including CBS/PSP, with therapeutic approaches
Knowledge Graph
Related Hypotheses (30)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Purinergic Signaling Polarization Control
Score: 0.55
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Membrane Cholesterol Gradient Modulators
Score: 0.52
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Flotillin-1 Stabilization Compounds
Score: 0.42
Extracellular Vesicle Biogenesis Modulation
Score: 0.34
Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
CYP46A1 Overexpression Gene Therapy
Score: 0.63
APOE-Dependent Autophagy Restoration
Score: 0.61
PARP1 Inhibition Therapy
Score: 0.58
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.53
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51
Senescence-Associated Myelin Lipid Remodeling
Score: 0.51
Ganglioside Rebalancing Therapy
Score: 0.50
Lysosomal Calcium Channel Modulation Therapy
Score: 0.49
Lysosomal Enzyme Trafficking Correction
Score: 0.49
Orexin-Microglia Modulation Therapy
Score: 0.49
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Complement C1q Mimetic Decoy Therapy
Score: 0.48
Show 25 more
Related Analyses (24)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Show 19 more
Related Experiments (26)
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.46
Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.46
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.46
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.46
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.46
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.46
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.46
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.46
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.46
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.46
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.46
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.46
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.46
Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.46
Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.46
Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.46
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.46
Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.46
Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.46
Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.46
Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.46
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.46
Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.46
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.46
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.46
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.46
Show 21 more
See Also (15)
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 10 hypotheses
WNK1 Kinase in Neurodegeneration
mechanism · Pages share 10 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 10 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 10 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 10 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 10 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 10 hypotheses
ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 10 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 10 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 10 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 10 hypotheses
Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 10 hypotheses
T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 10 hypotheses
Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 10 hypotheses
synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 10 hypotheses
Show 10 more